Method for the treatment of benign prostatic hypertrophy

Details Method for the treatment of benign prostatic hypertrophy Method for the treatment of benign prostatic hypertrophy

1979-10-05

1980-12-02

Goldberg, Jerome D.

Drug, bio-affecting and body treating compositions

Fermentate of unknown chemical structure

Having a known elemental analysis

A61K 3500

Patent

active

042371171

ABSTRACT:
The present invention is concerned with a method for the treatment of benign prostatic hypertrophy in male humans, comprising administering an effective amount of a compound selected from the group consisting of partricin, C.sub.1 -C.sub.6 alkyl ester of partricin and C.sub.1 -C.sub.6 alkyl ester of N-mono- and N,N-disubstituted partricin, the N-substituents being C.sub.1 -C.sub.6 alkyl or carboxylic acyl, to a human male suffering from benign prostatic hypertrophy.

REFERENCES:
patent: 3773925 (1973-11-01), Bruzzese et al.
patent: 3780173 (1973-12-01), Bruzzese et al.
patent: 3961047 (1976-06-01), Bruzzese et al.
patent: 3961048 (1976-06-01), Delliacqua et al.
patent: 4017603 (1977-04-01), Ferrari et al.

Affiliated with

Also associated with

Rating

Method for the treatment of benign prostatic hypertrophy does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method for the treatment of benign prostatic hypertrophy, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for the treatment of benign prostatic hypertrophy will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2283684